Chemical Component Summary

Name FUSIDIC ACID
Identifiers (2Z)-2-[(3beta,4beta,5alpha,8alpha,9beta,11beta,13alpha,16beta,17Z)-16-(acetyloxy)-3,11-dihydroxy-4,8,10,14-tetramethylgonan-17-ylidene]-6-methylhept-5-enoic acid
(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methyl-hept-5-enoic acid
Formula C31 H48 O6
Molecular Weight 516.71 g/mol
Type non-polymer
Isomeric SMILES C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@H]2[C@H](O)C[C@H]2\C([C@H](C[C@]12C)OC(C)=O)=C(/CCC=C(C)C)C(O)=O
InChI InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1
InChI Key IECPWNUMDGFDKC-MZJAQBGESA-N

Chemical Details

Formal Charge 0
Atom Count 85
Chiral Atom Count 10
Chiral Atoms C3 C4 C5 C8 C9 C10 C11 C13 C14 C16
Bond Count 88
Aromatic Bond Count 0

Drug Info: DrugBank

DrugBank ID DB02703   (Stereoisomeric match)
Name Fusidic Acid
Groups approved
Description An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis.
Synonyms
  • Fucidate
  • Fucidin acid
  • Fusidate
  • Fusidic acid
  • Fusidine
  • Ramycin
[more]
Salts Fucidate Sodium
Brand Names
  • Fucidin Cream 2%
  • Fucidin Film Coated Tab 250mg
  • Fucidin H
  • Fucidin Intertulle 2%
  • Fucidin Leo Injection Kit
  • Fucidin Leo Sus 246mg/5ml
  • Fucidin Ointment 2%
  • Fucithalmic
  • Fucidin
  • Fucidine
  • Fudic
  • Taksta
[more]
Affected Organism Enteric bacteria and other eubacteria
Indication For the treatment of bacterial infections.
Pharmacology Fusidic acid is a bacteriostatic antibiotic that is often used topically in creams and eyedrops, but may also be given systemically as tablets or injections.
Mechanism of action Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.
Route of administration
  • intravenous
  • ophthalmic
  • oral
  • topical
Categories
  • Anti-Bacterial Agents
  • Protein Synthesis Inhibitors
ATC-Code
  • D06AX01
  • D09AA02
  • J01XC01
  • S01AA13
CAS number 6990-06-3
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682